Patient-Surgeon Gender Concordance Does Not Impact Postoperative Mortality
By Elana Gotkine HealthDay Reporter
MONDAY, Nov. 27, 2023 -- Postoperative mortality is similar regardless of patient-surgeon gender concordance, according to a study published online Nov. 22 in The BMJ.
Christopher J.D. Wallis, M.D., Ph.D., from the University of Toronto, and colleagues conducted a retrospective observational study in acute care hospitals in the United States to examine whether patient-surgeon gender concordance is associated with mortality after surgery. Data were included for 2,902,756 patients who had one of 14 major elective or nonelective surgeries in 2016 to 2019.
Overall, 44.4 percent had operations done by surgeons of the same gender (41.4 percent male patient and male surgeon; 3.0 percent female patient and female surgeon) and 55.6 percent were by surgeons of a different gender (1.8 percent male patient and female surgeon; 53.8 percent female patient and male surgeon). The researchers found that the adjusted 30-day mortality was 2.0, 1.7, 1.5, and 1.3 percent for male patient-male surgeon dyads, male patient-female surgeon dyads, female patient-male surgeon dyads, and female patient-female surgeon dyads, respectively. Patient-surgeon gender concordance was associated with slightly lower and higher mortality for female and male patients, respectively (adjusted risk differences, −0.2 and 0.3 percentage points, respectively), but the difference was not clinically meaningful.
"We found that postoperative mortality was similar among the four types of patient-surgeon gender dyads," the authors write. "The associations were heterogeneous across different types of surgical procedures, with no significant findings observed for nonelective surgeries."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2023-11-28 02:32
Read more
- Beta Blockers Unnecessary for Folks Without Heart Failure; May Be Linked to Depression
- Camurus Provides Regulatory Update on the US NDA for CAM2029 in Acromegaly
- Gilead and Merck Announce Phase 2 Data Showing a Treatment Switch to an Investigational Oral Once-Weekly Combination Regimen of Islatravir and Lenacapavir Maintained Viral Suppression in Adults at Week 48
- American College of Chest Physicians, Oct. 6-9
- ASN: Empagliflozin Offers Lasting Cardiorenal Benefit in CKD Patients
- 2011 to 2022 Saw Increase in Autism Diagnoses Among Children, Adults
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions